Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

80.31
Delayed Data
As of Jun 23
 +1.11 / +1.40%
Today’s Change
49.51
Today|||52-Week Range
80.48
+35.68%
Year-to-Date

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Republicans Present Healthcare Bill: Top 5 Gainers
Jun 23 / Zacks.com - Paid Partner Content
Trader's Daily Notebook: Market's All Over the Map
Jun 22 / TheStreet.com - Paid Partner Content
Trader's Daily Notebook: Price Momentum Needs to Stick Around
Jun 23 / TheStreet.com - Paid Partner Content
4 Stocks & ETFs to Buy on Clovis' Positive Drug Data
Jun 21 / Zacks.com - Paid Partner Content
5 Reasons Why Biotech ETFs are Soaring
Jun 22 / Zacks.com - Paid Partner Content
Trader's Daily Notebook: Stick With the Numbers on the Screen
Jun 20 / TheStreet.com - Paid Partner Content

Performance

1 month+15.60% 3 years+17.18%
3 months+18.22% 5 years+23.13%
1 year+47.52% Since inception+15.32%
Data through 06/24/2017

Quote Details

Previous close$79.20
Open day’s range78.11 – 80.48
Net asset value (NAV)80.36 (06/23/2017)
Daily volume7,132,986
Average volume (3 months)4,312,510
Data as of 7:59pm ET, 06/23/2017

Peer Comparisonvs. Health ETFs

 XBICategory
Performance 5-yr return+23.13%+16.30%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.771.14
Net assets$3.0B$2.9B
Average market cap$5.0B$28.9B
Average P/E--22.4
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
EXAS Exact Sciences Corp3.36%
VRTX Vertex Pharmaceuticals Inc3.31%
REGN Regeneron Pharmaceuticals2.98%
IONS Ionis Pharmaceuticals Inc2.75%
BIVV Bioverativ Inc2.62%
PBYI Puma Biotechnology Inc2.58%
ALNY Alnylam Pharmaceuticals Inc2.57%
ABBV AbbVie2.52%
GILD Gilead Sciences2.39%
BMRN Biomarin Pharmaceutical Inc2.38%